Shanghai Rendu Biotechnology Balance Sheet Health
Financial Health criteria checks 6/6
Shanghai Rendu Biotechnology has a total shareholder equity of CN¥956.1M and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥1.0B and CN¥84.8M respectively.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥629.93m |
| Equity | CN¥956.07m |
| Total liabilities | CN¥84.76m |
| Total assets | CN¥1.04b |
Recent financial health updates
No updates
Recent updates
There Are Some Holes In Shanghai Rendu Biotechnology's (SHSE:688193) Solid Earnings Release
May 06
We Like These Underlying Return On Capital Trends At Shanghai Rendu Biotechnology (SHSE:688193)
Apr 17What Shanghai Rendu Biotechnology Co., Ltd.'s (SHSE:688193) 29% Share Price Gain Is Not Telling You
Mar 08Financial Position Analysis
Short Term Liabilities: 688193's short term assets (CN¥887.2M) exceed its short term liabilities (CN¥72.6M).
Long Term Liabilities: 688193's short term assets (CN¥887.2M) exceed its long term liabilities (CN¥12.2M).
Debt to Equity History and Analysis
Debt Level: 688193 is debt free.
Reducing Debt: 688193 had no debt 5 years ago.
Debt Coverage: 688193 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 688193 has no debt, therefore coverage of interest payments is not a concern.